Literature DB >> 23584381

Targeting psychoemotional stress to treat prostate cancer.

George Kulik1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 23584381      PMCID： PMC3739661          DOI： 10.1038/aja.2013.30

Source DB:  PubMed          Journal:  Asian J Androl        ISSN： 1008-682X            Impact factor:   3.285


× No keyword cloud information.
  9 in total

1.  Antihypertensive drug use and the risk of prostate cancer (Canada).

Authors:  Linda Perron; Isabelle Bairati; François Harel; François Meyer
Journal:  Cancer Causes Control       Date:  2004-08       Impact factor: 2.506

2.  Epinephrine protects cancer cells from apoptosis via activation of cAMP-dependent protein kinase and BAD phosphorylation.

Authors:  Konduru S R Sastry; Yelena Karpova; Sergey Prokopovich; Adrienne J Smith; Brian Essau; Avynash Gersappe; Jonathan P Carson; Michael J Weber; Thomas C Register; Yong Q Chen; Raymond B Penn; George Kulik
Journal:  J Biol Chem       Date:  2007-03-12       Impact factor: 5.157

3.  Cancer fear and mood disturbance after radical prostatectomy: consequences of biochemical evidence of recurrence.

Authors:  Philip M Ullrich; Mark R Carson; Susan K Lutgendorf; Richard D Williams
Journal:  J Urol       Date:  2003-04       Impact factor: 7.450

4.  Use of β-blockers is associated with prostate cancer-specific survival in prostate cancer patients on androgen deprivation therapy.

Authors:  Helene Hartvedt Grytli; Morten Wang Fagerland; Sophie D Fosså; Kristin Austlid Taskén; Lise Lund Håheim
Journal:  Prostate       Date:  2012-07-20       Impact factor: 4.104

5.  Does β-adrenoceptor blocker therapy improve cancer survival? Findings from a population-based retrospective cohort study.

Authors:  Sunil M Shah; Iain M Carey; Christopher G Owen; Tess Harris; Stephen Dewilde; Derek G Cook
Journal:  Br J Clin Pharmacol       Date:  2011-07       Impact factor: 4.335

6.  The norepinephrine-driven metastasis development of PC-3 human prostate cancer cells in BALB/c nude mice is inhibited by beta-blockers.

Authors:  Daniel Palm; Kerstin Lang; Bernd Niggemann; Theodore L Drell; Kai Masur; Kurt S Zaenker; Frank Entschladen
Journal:  Int J Cancer       Date:  2006-06-01       Impact factor: 7.396

7.  Behavioral stress accelerates prostate cancer development in mice.

Authors:  Sazzad Hassan; Yelena Karpova; Daniele Baiz; Dana Yancey; Ashok Pullikuth; Anabel Flores; Thomas Register; J Mark Cline; Ralph D'Agostino; Nika Danial; Sandeep Robert Datta; George Kulik
Journal:  J Clin Invest       Date:  2013-01-25       Impact factor: 14.808

8.  Use of blood-pressure-lowering medication and risk of prostate cancer in the Cancer Prevention Study II Nutrition Cohort.

Authors:  Carmen Rodriguez; Eric J Jacobs; Anusila Deka; Alpa V Patel; Elizabeth B Bain; Michael J Thun; Eugenia E Calle
Journal:  Cancer Causes Control       Date:  2008-12-09       Impact factor: 2.506

9.  Src activation by β-adrenoreceptors is a key switch for tumour metastasis.

Authors:  Guillermo N Armaiz-Pena; Julie K Allen; Anthony Cruz; Rebecca L Stone; Alpa M Nick; Yvonne G Lin; Liz Y Han; Lingegowda S Mangala; Gabriel J Villares; Pablo Vivas-Mejia; Cristian Rodriguez-Aguayo; Archana S Nagaraja; Kshipra M Gharpure; Zheng Wu; Robert D English; Kizhake V Soman; Mian M K Shahzad; Mian M K Shazhad; Maya Zigler; Michael T Deavers; Alexander Zien; Theodoros G Soldatos; David B Jackson; John E Wiktorowicz; Madeline Torres-Lugo; Tom Young; Koen De Geest; Gary E Gallick; Menashe Bar-Eli; Gabriel Lopez-Berestein; Steve W Cole; Gustavo E Lopez; Susan K Lutgendorf; Anil K Sood
Journal:  Nat Commun       Date:  2013       Impact factor: 14.919
  9 in total
  1 in total

1.  Systems modeling of anti-apoptotic pathways in prostate cancer: psychological stress triggers a synergism pattern switch in drug combination therapy.

Authors:  Xiaoqiang Sun; Jiguang Bao; Kyle C Nelson; King Chuen Li; George Kulik; Xiaobo Zhou
Journal:  PLoS Comput Biol       Date:  2013-12-05       Impact factor: 4.475
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.